GenVec Inc.

(GNVC) Trade

By |

Profile

Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear.

Contact Information

Website: www.genvec.com
Email: dswirsky@GENVEC.com
Main Phone: +1 240 632-0740
Address: 910 Clopper Road
Address 2: Suite 220N
State: MD
City / Town: Gaithersburg
Country: USA
Postal Code: 20878

Issuer Information

Exchange: NSC
CEO: Douglas J. Swirsky
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear.

Contact Information

Website: www.genvec.com
Email: dswirsky@GENVEC.com
Main Phone: +1 240 632-0740
Address: 910 Clopper Road
Address 2: Suite 220N
State: MD
City / Town: Gaithersburg
Country: USA
Postal Code: 20878

Issuer Information

Exchange: NSC
CEO: Douglas J. Swirsky
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 10.44 52 Wk Low 2.70
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 2,273,632.00 EPS (TTM) -3.66 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Douglas J. Swirsky 1,000
Douglas J. Swirsky 1,000
Stefan D. Loren 1,000
Stefan D. Loren 1,000
Stefan D. Loren 1,000
Stefan D. Loren 1,000
Stefan D. Loren 1,000
Douglas E. Brough 1,000
Douglas E. Brough 1,000
Douglas E. Brough 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 7 7 7 7
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 01/25/17 01/25/17 01/25/17 01/25/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 3 3